Open access · US-GOV via ClinicalTrials.gov Clinical trial

An Open-Label, Single-Arm Study to Assess the Safety of Youniqor Consumption in Healthy Adults

Authors not listed

YOXLO B.V. · 2026

Dysbiosis Human Randomized controlled trial

Abstract

The goal of this clinical trial is to evaluate the safety and tolerability of the nutritional supplement Youniqor in healthy older adults. The main questions it aims to answer are: Is Youniqor safe and well tolerated when taken daily by healthy adults aged 60 to 80 years? Are there any adverse events or clinically relevant changes in vital signs or laboratory parameters during the study period? Participants will: Take Youniqor daily for 8 weeks Attend scheduled study visits for safety assessments, including vital signs, blood and urine tests, and electrocardiograms Report any adverse events during the study period

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-07 MST

Cite this

APA

Anonymous. (2026). An Open-Label, Single-Arm Study to Assess the Safety of Youniqor Consumption in Healthy Adults. <em>YOXLO B.V.</em>. https://clinicaltrials.gov/study/NCT07442097

Vancouver

Anonymous. An Open-Label, Single-Arm Study to Assess the Safety of Youniqor Consumption in Healthy Adults. YOXLO B.V.. 2026.

BibTeX

@misc{anon2026AnOpen, title = {An Open-Label, Single-Arm Study to Assess the Safety of Youniqor Consumption in Healthy Adults}, author = {Anonymous}, journal = {YOXLO B.V.}, year = {2026}, }